Repligen Corporation – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: RGEN
Share price (9/22/26): $186.75
Market cap (9/22/26): $9.136 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 107 pages Agreement and Plan of Merger Among Repligen Corporation, Bravo Merger Sub I, Inc., Bravo Merger Sub II, LLC, and Biolife Solutions, Inc. Dated as of July 21, 2026

from 8-K 85 pages Stock Purchase Agreement by and Among Repligen Corporation, C Technologies, Inc., and Craig Harrison Dated as of April 25, 2019

from 8-K 157 pages Agreement and Plan of Merger and Reorganization by and Among Repligen Corporation, Top Hat, Inc., Swing Time, LLC, Spectrum, Inc., and Roy T. Eddleman, as Securityholder Representative Dated as of June 22, 2017

from 8-K 61 pages Stock Purchase Agreement by and Among Novasep Process Sas and John Connors (Collectively, the “Sellers”) and Repligen Corporation (“Purchaser”) Date: December 14, 2016

from 8-K 53 pages Novozymes Biopharma Dk a/S, Novozymes Biopharma Sweden Ab, Repligen Corporation and Repligen Sweden Ab Asset Transfer Agreement

from 10-Q ~20 pages Plan of reorganization, merger, acquisition or similar

from 8-K/A ~5 pages Exhibit 2.2 Common Stock Purchase Warrant

from 8-K/A ~20 pages Exhibit 2.1 Patent Purchase Agreement

from 8-K ~5 pages Collateral Assignment of Patents

from 8-K ~5 pages Common Stock Purchase Warrant

from 8-K ~20 pages Patent Purchase Agreement